Inovio Pharmaceuticals
INO
#8898
Rank
โ‚น12.77 B
Marketcap
โ‚น185.96
Share price
2.48%
Change (1 day)
-47.33%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2025 (TTM): โ‚น15.62 Million

According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น16.38 Million. In 2024 the company made a revenue of โ‚น18.68 Million a decrease over the revenue in the year 2023 that were of โ‚น69.26 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น15.62 M-16.38%
2024 โ‚น18.68 M-73.03%
2023 โ‚น69.26 M-91.84%
2022 โ‚น0.84 B542.86%
2021 โ‚น0.13 B-75.63%
2020 โ‚น0.54 B84.84%
2019 โ‚น0.29 B-86.24%
2018 โ‚น2.13 B-20.94%
2017 โ‚น2.69 B12.16%
2016 โ‚น2.40 B-10.86%
2015 โ‚น2.69 B306.84%
2014 โ‚น0.66 B-20.35%
2013 โ‚น0.83 B268.95%
2012 โ‚น0.22 B-56.48%
2011 โ‚น0.51 B88.19%
2010 โ‚น0.27 B-34.93%
2009 โ‚น0.42 B319.72%
2008 โ‚น0.10 B-46.56%
2007 โ‚น0.18 B22.83%
2006 โ‚น0.15 B-37.57%
2005 โ‚น0.24 B386.75%
2004 โ‚น50.54 M1278.56%
2003 โ‚น3.66 M-59.66%
2002 โ‚น9.08 M
2000 โ‚น0.25 B-32.09%
1999 โ‚น0.38 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น5.640 T 34,433,942.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 50,537,640.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น51.47 B 314,140.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.064 T 30,916,280.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น5.770 T 35,228,624.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น3.804 T 23,227,647.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
โ‚น2.612 T 15,951,681.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
โ‚น56.76 M 246.52%๐Ÿ‡บ๐Ÿ‡ธ USA